Journal profile · Neuroscience-Neurology
Ibrain
ISSN 2313-1934 · eISSN 2769-2795 · Wiley-VCH · Germany
Ibrain: fully open access; APC about USD 2,800; median 175 days to acceptance (46 articles, last 24 months); acceptance rate 22% (journal website); 30 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Ibrain is published by Wiley-VCH. By OpenAlex counts of its recent articles, its largest topics are Neuroinflammation and Neurodegeneration Mechanisms, Anesthesia and Neurotoxicity Research and Alzheimer's disease research and treatments, together about 24.8% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Aims of the journal Ibrain is an international and open access journal in the field of neuroscience. The journal publishes the advanced research about brain, spinal cord and nerve, so as to provide a communication platform about basic & translational science and clinical practice for neuroscientists. Ibrain welcomes submissions all over the world that will benefit the development of neuroscience. Scope and topics Ibrain is interested in the topics in relation to diseases of the brain, spinal cord and nerve, including but not limited to clinical medicine, molecule diagnostics, epigenetics/genetics, cell biology, drug discovery, evolutionary medicine, nanotechnology or artificial intelligence. The journal is focused on clinical and experimental advances that provide the characterization, pathogenic mechanism, diagnostic, therapeutic, medical innovations or techniques for the diseases of the brain, spinal cord and nerve. Topics of interest include, but are not limited to: Brain Stroke Brain injury Brain tumor Head and neck disease Cerebral ischemia and hypoxia Cognition and psychiatric disorders Dementia Infection of the brain Epilepsy Development and stem cells Brain pathology Perioperative sedation Spinal cord Spinal cord injury Spinal cord repair Paralysis Human movement or paresthesia Nerve Cellular and molecular neuroscience Regeneration and plasticity Neurodegeneration and repair Neurodegenerative diseases Nerve injury Neural circuit Neural technology Neuropathy Neuralgia Neurotherapeutics Nerve block
From the journal's Aims & Scope
Research area (LetPub): Neuroscience-Neurology
Editor-in-chief Ji HuPublisher website
Editorial board by country: 16 in mainland China (about 42%); most named Mainland China 16, United Kingdom 6, United States 4, Germany 4, Australia 4 (38 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience8.6%
- Anesthesia and Neurotoxicity ResearchNeuroscience8.6%
- Alzheimer's disease research and treatmentsMedicine7.6%
- Nerve injury and regenerationNeuroscience6.9%
- Anesthesia and Sedative AgentsMedicine6.2%
- Spinal Cord Injury ResearchMedicine5%
- Neonatal and fetal brain pathologyMedicine5%
- Pain Mechanisms and TreatmentsMedicine4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Cognitive Neuroscience | Q2 | 57/129 | 56th |
| Neurology | Q3 | 102/201 | 49th |
| Behavioral Neuroscience | Q3 | 52/93 | 44th |
| Cellular and Molecular Neuroscience | Q3 | 70/102 | 31st |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PMCPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 4LetPub ·
- CiteScore (publisher) 2025
- 4Publisher website ·
- SJR 2026-06
- 0.72LetPub ·
- SNIP 2026-06
- 0.64LetPub ·
- h-index
- 17OpenAlex ·
- i10-index
- 42OpenAlex ·
- 2-year mean citedness
- 2.87OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year (publisher) 2025
- 22Publisher website ·
- Downloads per year (publisher) 2025
- 109,584Publisher website ·
Articles by year OpenAlex count · 356 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 27 | 27 | 444 |
| 2025 | 30 | 30 | 472 |
| 2024 | 46 | 46 | 315 |
| 2023 | 58 | 58 | 153 |
| 2022 | 73 | 73 | 101 |
| 2021 | 48 | 43 | 12 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
175 daysMedian, submission to acceptance · P25–P75 124 days – 210 days
- Acceptance to online
- median 12 days (49 articles)
- Submission to online
- median 188 days
- Sample
- 46 articles with submission and acceptance dates (59 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- Acceptance rate (publisher) 2025
- 22%Publisher website ·
- Submission to first decision 2025
- 16 daysPublisher website ·
- Submission to acceptance 2025
- 169 daysPublisher website ·
- Acceptance to publication 2025
- 13 daysPublisher website ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,428 / GBP 2,060 / USD 2,800 | Yes | CC BY | |
| OpenAlex | USD 0 | — | — | |
| LetPub | USD 2,800 / GBP 2,060 / EUR 2,428 | Yes | — | |
| Publisher website | No APC | — | — |
Other charges and waivers (author guidelines)
- Other fees
- Charged; see the journal's website for the amount
- Submission fee
- Charged; see the journal's website for the amount
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 3–6
- Reference style
- AMA
- Suggested reviewers
- Optional
- Highlights
- Required
- Graphical abstract
- Required
Article types accepted10, with length limits
- case reportOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…Length not stated
- commentComments discuss published findings and ideas from a personal viewpoint.Length not stated
- letterOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…main text ≤ 1,200 words
- meta-analysisOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…Length not stated
- methodsMethods are news-style reports, and are published a few times a year to review techniques and technologies in fast-moving fields of research.Length not stated
- original articleOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…Length not stated
- research articleOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…main text ≤ 6,000 words
- reviewOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…Length not stated
- systematic reviewOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…Length not stated
- viewpointOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Open access, Peer review, Preprints
- Authorship Authorship
All listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version.
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Pot…
Source ↗Publisher website ·- Data availability Data Sharing and Data Accessibility
Please review Wiley’s policy here. This journal encourages data sharing.
Source ↗Publisher website ·- Open access Relevant Open Access Health Sciences journals
Authors may post the final published version immediately after publication. Model summary
CNS Neuroscience & Therapeutics (2008-Present)Brain Pathology (1990-Present)Neuroprotection (2022-Present)Brain-X (2023-Present)
Source ↗Publisher website ·- Peer review Peer Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Except where otherwise stated, manuscripts are single-blind peer reviewed by two reviewers. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.
Source ↗Publisher website ·- Preprints
Preprint policy: preprints are accepted. Model summary
Ibrain will consider articles previously available as preprints.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-VCH
- Country or region
- Germany
- Language
- English
- ISSN
- 2313-1934
- Electronic ISSN
- 2769-2795
- Society / sponsor
- Affiliated Hospital of Zunyi Medical University
- Latest issue on the website
- Volume 12, Issue 2 (2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Ibrain
How long does peer review take at Ibrain?
Based on the dates recorded on 46 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 175 days (interquartile range 124–210 days); authors report an average review time of about 10 weeks; the journal's website gives an acceptance rate of 22% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Ibrain?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 3–6; Reference style: AMA; Suggested reviewers: Optional; Highlights: Required; Graphical abstract: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Ibrain based?
Of the 38 board members whose country the journal's board page names, 16 (about 42%) are in mainland China; the countries named most often are Mainland China (16), United Kingdom (6) and United States (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Ibrain?
According to LetPub and DOAJ records, Ibrain is indexed in Scopus and DOAJ. The journal's website also lists PMC; that list has not been checked against each database.
Is Ibrain open access, and what is the APC?
Ibrain is a fully open-access journal. APC about USD 2,800.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .